16 minutes agoBoys of this age are more vulnerable to the side effects of Ovidius vaccines
Periskopi(5 years ago)
(5 years ago)JCVI did not recommend vaculation of healthy children between 12 and 17 years of age, but exceeded the issue to leading medical officials, who are expected to make a final decision next week. Healthy boys may be more likely to be hospitalised with a rare side effect of Pfizer vaccine. B O NTech Coved, that [...]
Healthy boys may be more likely to be hospitalised with a rare side effect of Pfizer vaccine. B O NTech Coved, which causes heart inflammation rather than Coddy himself, according to American studious, writes The Guardian.
Medical data analysis suggests that boys between the ages of 12 and 15 without chronic illness are four to six times more likely to be diagnosed with myocards related to vaccine than to end up in a hospital with Covid broadcasts news.
Most of the children who experienced the rare side effect had symptoms within days from the second dose of Pfizer vaccine. BioNTech, although a similar side effect is seen with the Moderna vaccine.
Saul Faust, professor of pediatric immunology and infectious diseases at Southampton University, has stated that findings justify careful access to teen vaccines.
JCVI did not recommend vaculation of healthy children between 12 and 17 years of age, but exceeded the issue to leading medical officials, who are expected to make a final decision next week.
Even in the recent study by Tracy Hoeg and other colleagues at the University of California, it proved that the myocard scale following two doses of Pfizer vaccines/ BioNTech, 162.2 cases for healthy boys aged 12 to 15, and 94 cases for 1 million healthy boys aged 16 to 17.
Most of the miocard appears after the second dose of the vaccine, so offering one dose can protect children by reducing the risk of side effects.
And we can either change the first or second doses or combine vaccines in different ways to avoid danger, but once we better understand the physiology,” says of The Guardian Doctor Faust.
Dr. Adam Finn, a member of JCVI at the University of Bristol, also says: "I stand by JCVI's advice, which will not continue in this period with the inoculation of healthy children aged 12 to 15 on the basis of risk and benefit of health results. And this in view of the current uncertainty since there is a small but reliable danger that the damage can result from greater than modest benefits”.
